Background The growing burden of diabetes worldwide is a threat to tuberculosis (TB)
control. Drug-induced liver injury (DILI) due to TB drugs is a significant concern and there is …

Drug-induced liver injury (DILI) is a common adverse drug reaction leading to the
interruption of tuberculosis (TB) therapy. We aimed to identify whether the hepatitis B virus …

Background The risk of anti-tuberculosis (TB) drug-induced liver injury (DILI) in patients with
chronic viral hepatitis (CVH) is not clear. The aim of this study was to investigate incidence …

OBJECTIVES: To investigate the risk factors for drug-induced liver injury (DILI) during the
treatment of multidrug-resistant tuberculosis (MDR-TB) and to compare the frequency of DILI …

Background: Tuberculosis (TB) is a major global health problem, mainly in developing
countries. Despite the availability of highly effective first-line antitubercular (ATT) drugs, ATT …

Background and Aims: Anti-tuberculosis drugs remain as an important cause of drug-
induced liver injury (DILI) worldwide. Adverse drug reactions reduce the effectiveness of …

Objective: To analyze the influencing factors of anti-tuberculosis drug-induced liver injury
(ATB-DILI) in patients with pulmonary tuberculosis complicated with diabetes mellitus (PTB …

Background Drug-induced liver injury (DILI) may lead to the discontinuation of
antituberculosis (anti-TB) treatment (ATT). Some studies have suggested that metabolic …

Abstract Background and Aims Anti‐tuberculosis drugs remain as an important cause of
drug‐induced liver injury (DILI) worldwide. Adverse drug reactions reduce the effectiveness …

Background Drug-induced liver injury (DILI) is one of the most serious problems
complicating anti-tuberculosis (anti-TB) treatment. The aim of the study was to assess the …